Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,895 | -26,522 | -23,425 | -17,514 | -3,608 |
| Depreciation Amortization | 280 | 657 | 800 | 324 | 20 |
| Accounts receivable | N/A | N/A | N/A | 45 | N/A |
| Accounts payable and accrued liabilities | 514 | -240 | -341 | 14 | -600 |
| Other Working Capital | 456 | 1,274 | -747 | 477 | -795 |
| Other Operating Activity | 3,549 | 4,217 | 3,388 | 4,660 | 984 |
| Operating Cash Flow | $-22,096 | $-20,614 | $-20,325 | $-11,994 | $-3,999 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,630 | 33,280 | -9,990 | -31,716 | 250 |
| PPE Investments | -14 | -75 | -38 | -12 | -2 |
| Net Acquisitions | N/A | N/A | N/A | 7,464 | N/A |
| Other Investing Activity | 0 | 0 | 1,165 | 3,000 | 0 |
| Investing Cash Flow | $3,616 | $33,205 | $-8,863 | $-21,264 | $248 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,940 |
| Debt Repayment | 0 | 9,748 | 0 | N/A | N/A |
| Common Stock Issued | 7,170 | 3,455 | 23,782 | 46,488 | N/A |
| Financing Cash Flow | $7,170 | $13,203 | $23,782 | $46,488 | $2,940 |
| Beginning Cash Position | 35,921 | 10,127 | 15,533 | 2,303 | 3,114 |
| End Cash Position | 24,611 | 35,921 | 10,127 | 15,533 | 2,303 |
| Net Cash Flow | $-11,310 | $25,794 | $-5,406 | $13,230 | $-811 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,096 | -20,614 | -20,325 | -11,994 | -3,999 |
| Capital Expenditure | -14 | -75 | -38 | -12 | -2 |
| Free Cash Flow | -22,110 | -20,689 | -20,363 | -12,006 | -4,001 |